UiPath (NYSE:PATH) Posts Earnings Results, Beats Estimates By $0.01 EPS

UiPath (NYSE:PATH) posted its quarterly earnings results on Thursday. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.03 by $0.01, Briefing.com reports. UiPath had a negative net margin of 6.41% and a negative return on equity of 2.97%. The business had revenue of $316.00 million during the quarter, compared to analyst estimates of $303.69 million. During the same period in the prior year, the firm earned ($0.09) earnings per share. The firm’s revenue was up 10.0% compared to the same quarter last year. UiPath updated its FY 2025 guidance to EPS and its Q3 2025 guidance to EPS.

UiPath Price Performance

PATH stock opened at $11.97 on Friday. The stock has a market capitalization of $6.86 billion, a price-to-earnings ratio of -74.84 and a beta of 0.87. The company has a 50-day moving average of $12.20 and a two-hundred day moving average of $16.71. UiPath has a 52-week low of $10.37 and a 52-week high of $27.87.

Analyst Upgrades and Downgrades

PATH has been the subject of a number of research analyst reports. Morgan Stanley reiterated an “equal weight” rating and issued a $15.00 target price on shares of UiPath in a research report on Friday. DA Davidson increased their price objective on UiPath from $13.00 to $15.00 and gave the stock a “neutral” rating in a report on Friday. TD Cowen lowered their target price on UiPath from $17.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday. Truist Financial reaffirmed a “hold” rating and issued a $14.00 target price (down from $32.00) on shares of UiPath in a research report on Thursday, May 30th. Finally, JPMorgan Chase & Co. reduced their price target on UiPath from $28.00 to $19.00 and set an “overweight” rating for the company in a report on Thursday, May 30th. Sixteen research analysts have rated the stock with a hold rating and two have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $17.71.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.